Semaglutide before prostate removal for eligible men
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether taking semaglutide before prostate removal surgery can help men with intermediate-risk prostate cancer and high BMI. The treatment is given for 3-6 months before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older.
- You have intermediate-risk prostate cancer confirmed by biopsy.
- You are scheduled for prostate removal surgery, and your doctor agrees it can wait 3-6 months.
- Your body mass index (BMI) is greater than 35.
- You have not had hormone therapy for prostate cancer.
- You have not taken any GLP-1 medicines like Ozempic or Wegovy in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a GLP-1 receptor agonist (a type of diabetes drug that helps with weight loss) can help men with prostate cancer who are on hormone therapy (ADT) and have a high body mass index (BMI). It aims to see if it improves their health and outcomes.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This trial tests if semaglutide (a weekly injection) helps people who lost less weight than expected after gastric bypass or sleeve surgery. It's for patients who had a high BMI before surgery and are in a special support program.
This trial tests whether semaglutide (a medicine that helps control blood sugar and weight) can improve outcomes for people with type 1 diabetes who have a higher body weight. It may help if you have had type 1 diabetes for at least 3 years and have a BMI of 30 or more, or 27 or more with a related health problem.
This trial tests whether taking semaglutide (a once-weekly injection for weight loss) before a heart procedure called catheter ablation helps people with atrial fibrillation. It may help those with excess weight or obesity who have not used this type of medication before.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.